查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1758217

全球血管腹部主動脈血管瘤（AAA）市場

Endovascular Abdominal Aortic Aneurysm (AAA)
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 275 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球血管腹部主動脈血管瘤(AAA) 市場規模將達到 38 億美元

2024年，全球血管腹部主動脈血管瘤(AAA) 市場規模估計為30億美元，預計到2030年將達到38億美元，2024年至2030年的複合年成長率為4.1%。血管支架是本報告分析的細分市場之一，預計其複合年成長率為4.7%，到分析期結束時市場規模將達到27億美元。合成移植物細分市場在分析期間的複合年成長率估計為2.6%。

美國市場規模估計為 8.069 億美元，中國市場預計複合年成長率為 7.6%

預計2024年美國血管腹部主動脈血管瘤(AAA) 市場規模將達8.069億美元。作為世界第二大經濟體，中國市場規模預計將在2030年達到7.738億美元，在分析期間（2024-2030年）的複合年成長率為7.6%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為1.6%和3.2%。在歐洲，預計德國市場的複合年成長率為2.4%。

全球血管腹部主動脈血管瘤（AAA）市場－主要趨勢與促進因素摘要

哪些技術變革將重新定義 AAA 治療格局？

腹部主動脈血管瘤(AAA) 的治療正經歷從開放性手術修復到微創技術的模式轉移，主要代表是血管內動脈瘤修復 (EVAR)。血管支架設計、導管輸送系統和影像引導方面的技術進步，使 EVAR 成為許多高所得醫療保健系統中的主要治療方法。 EVAR 技術的核心是一種模組化血管支架，它可透過股動脈引入並精確放置在動脈瘤部位，從而有效地將薄弱的血管壁從體循環中隔離出來。向經皮、無縫線入路和低剖面設備的轉變顯著擴大了可治療的患者群體，包括那些手術風險高的患者。

下一代EVAR系統著重解剖適應性和長期密封性能。柵欄式和分叉式血管內技術的發展使外科醫生能夠治療曾被認為不適合傳統EVAR的短頸、成角頸或浸潤性內臟分支的動脈瘤。聚合物密封環、可複位移植物和整合成像標記等技術創新解決了內漏、移位和入路問題等常見併發症。此外，包括3D融合成像和機器人輔助導航在內的術中影像系統的出現，提高了手術精度，並減少了顯影劑和放射線暴露。這些技術進步不僅最佳化了治療效果，也影響全球治療指南和外科醫師的偏好。

哪些患者人口統計和風險狀況推動了臨床需求？

腹部主動脈血管瘤的負擔正在加重，這主要是由於世界人口老化以及吸菸、高血壓和高血脂症等可改變風險因素的普遍存在。腹主動脈瘤最常見於65歲或以上的男性，但流行病學研究也擴大認知到其在老年女性中的發生率。因此，一些已開發國家已經實施了針對高風險族群的篩檢計劃，尤其是65歲或以上的男性吸菸者。超音波篩檢的廣泛應用使得無症狀性動脈瘤的早期發現成為可能，從而擴大了在動脈瘤破裂前接受EVAR治療的患者群體。

對於手術風險較高的族群，例如老年患者和患有慢性阻塞性肺病(COPD)、腎功能不全和冠狀動脈疾病等併發症的患者，EVAR 是傳統開放性手術的可行治療方法。這導致三級醫院、門診手術中心甚至專門從事血管介入的混合手術室的需求增加。此外，由於移植物退化和動脈瘤囊擴大，越來越多的患者在初次 EVAR 後需要再次干預，這為更新、更耐用的移植物技術創造了第二個需求管道。儘管解剖學差異對通用設備的適用性構成了挑戰，但將女性納入 AAA 風險分層方案和偶然的動脈瘤影像學發現也促進了該手術的發展。

區域生態系和市場進入如何影響採用？

北美和西歐仍然是EVAR最成熟的市場，這得益於其高手術量、先進的醫院基礎設施以及優惠的報銷政策。美國在應用EVAR方面處於領先地位，這得益於大型醫療設備製造商的存在、正在進行的臨床試驗以及熟練的血管外科手術團隊。在歐洲，德國、英國和荷蘭等國家已展現出其公共醫療體系中強大的手術整合能力，EVAR佔擇期AAA修復手術的70%以上。在這些地區，政府資助的篩檢舉措進一步支持了患者識別和轉介至血管內治療。

亞太地區正逐漸成為重要的成長前沿，尤其是在日本、中國和韓國。老化和都市化導致這些地區血管疾病發生率上升。日本在技術應用方面一直處於領先地位，擁有豐富的手術經驗，並廣泛採用客製化柵欄式器械。在中國，不斷擴大的醫療基礎設施和不斷發展的國內器械製造商正在推動市場快速擴張。然而，報銷差距和培訓不足仍然是許多新興國家面臨的挑戰。在拉丁美洲和中東部分地區，技術應用速度較慢，但正在成長，尤其是在服務高所得患者群體的私人醫院。設備租賃、手術培訓計畫和混合手術室設置支援等打入市場策略已被證明在這些技術應用不足的地區行之有效。

推動 EVAR 市場成長的關鍵因素有哪些？

血管腹部主動脈血管瘤(AAA) 市場的成長受到多種因素的驅動，這些因素影響全球技術發展、手術普及率和患者就診機會。其中最主要的是全球動脈瘤盛行率的不斷上升，而人口老化、生活方式相關的風險因素以及篩檢的擴大進一步加劇了這一趨勢。隨著無症狀性動脈瘤的早期發現率不斷提高，選擇性 EVAR 作為一種比開放性手術更安全、創傷更小的替代方法，正日益受到青睞。這種轉變得益於血管支架系統的持續創新，即使在解剖結構複雜的病例中，該系統的貼合性、密封性和耐用性也得到了改善。

監管趨勢和支付方結構也推動了成長。 FDA核准了下一代設備，CE 標誌也擴展到涵蓋先進的柵欄式和分叉式解決方案，這推動了傳統和小眾解剖領域的臨床應用不斷增加。向價值導向的醫療保健模式轉變與 EVAR 較低的併發症率、較短的住院時間和較低的術後發病率相契合。醫院和外科中心正在投資混合手術室和整合影像系統來支援這些手術，這表明他們對血管內介入治療的長期效用充滿信心。

此外，該行業越來越重視培訓和教育，推出基於模擬的程序和全球外科醫生網路，以實現手術專業知識的標準化。遠端醫療的追蹤和穿戴式裝置的術後後續觀察相結合，進一步豐富了治療生態系統。同時，研發投入的不斷增加，尤其是在生物可吸收移植組件和人工智慧成像工具方面的投入，顯示 EVAR 技術仍處於活躍的進化階段。這些多方面的因素將推動手術量和設備創新的持續成長，並牢固確立 EVAR 在可預見的未來作為 AAA 治療的主導治療方法。

部分

產品類型（血管支架、合成移植物）；最終使用者（醫院最終使用者、門診手術中心最終使用者、其他最終使用者）

受訪公司範例（41家值得關注的公司）

  • Abbott Laboratories
  • Artivion Inc.
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Cordis Corporation
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • Endologix LLC
  • Getinge AB
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Lifetech Scientific Corp.
  • Lombard Medical Ltd.
  • Medtronic plc
  • MicroPort Scientific Corp.
  • Terumo Corporation

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global Industry Analysts 並未遵循查詢 LLM 或特定產業SLM 的典型規範，而是建立了一個來自全球領域專家的精選內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP36838

Global Endovascular Abdominal Aortic Aneurysm (AAA) Market to Reach US$3.8 Billion by 2030

The global market for Endovascular Abdominal Aortic Aneurysm (AAA) estimated at US$3.0 Billion in the year 2024, is expected to reach US$3.8 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Stent Graft, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Synthetic Fabric Graft segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$806.9 Million While China is Forecast to Grow at 7.6% CAGR

The Endovascular Abdominal Aortic Aneurysm (AAA) market in the U.S. is estimated at US$806.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$773.8 Million by the year 2030 trailing a CAGR of 7.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.4% CAGR.

Global Endovascular Abdominal Aortic Aneurysm (AAA) Market - Key Trends & Drivers Summarized

What Technological Shifts Are Redefining the Treatment Landscape for AAA?

The management of abdominal aortic aneurysms (AAA) has seen a paradigm shift from open surgical repair to minimally invasive techniques, primarily led by endovascular aneurysm repair (EVAR). Technological advancements in stent graft design, catheter delivery systems, and imaging guidance have enabled EVAR to become the dominant intervention method in many high-income healthcare systems. The core of EVAR technology lies in modular stent grafts that can be introduced via femoral artery access and deployed precisely at the aneurysm site, effectively excluding the weakened vessel wall from systemic circulation. The shift toward percutaneous, suture-less access and low-profile devices has significantly expanded the treatable patient population, including those with higher surgical risk.

Next-generation EVAR systems are emphasizing anatomical adaptability and long-term sealing performance. The development of fenestrated and branched endografts has allowed surgeons to treat aneurysms that were once considered unsuitable for conventional EVAR due to short or angulated necks, or involvement of visceral branches. Innovations such as polymer-based sealing rings, repositionable grafts, and integrated imaging markers are addressing common complications like endoleaks, migration, and access issues. Additionally, the emergence of intraoperative imaging systems, including 3D fusion imaging and robotic-assisted navigation, is streamlining procedural accuracy and reducing contrast and radiation exposure. These technological strides are not only optimizing procedural outcomes but also influencing treatment guidelines and surgeon preferences globally.

Which Patient Demographics and Risk Profiles Are Driving Clinical Demand?

The burden of abdominal aortic aneurysms is rising, largely influenced by the aging global population and prevalence of modifiable risk factors such as smoking, hypertension, and hyperlipidemia. AAAs are most commonly diagnosed in men aged 65 and older, though incidence among older women is increasingly recognized in epidemiological studies. As a result, screening programs have been introduced in several developed countries targeting at-risk populations, particularly male smokers over the age of 65. The broader implementation of ultrasound-based screening has led to earlier detection of asymptomatic aneurysms, thus expanding the pool of patients eligible for elective EVAR procedures before rupture occurs.

In high-risk surgical populations-such as the elderly or those with comorbidities like chronic obstructive pulmonary disease (COPD), renal dysfunction, or coronary artery disease-EVAR offers a viable treatment alternative to traditional open repair. This has driven demand across tertiary hospitals, ambulatory surgical centers, and even hybrid operating rooms tailored for vascular interventions. Furthermore, the growing number of patients requiring reintervention after initial EVAR due to graft degeneration or aneurysm sac enlargement is creating a secondary demand channel for newer, more durable graft technologies. The inclusion of women in AAA risk stratification protocols and the detection of aneurysms through incidental imaging are also contributing to procedural growth, though anatomical differences still pose challenges for universal device applicability.

How Are Regional Ecosystems and Market Access Influencing Uptake?

North America and Western Europe remain the most mature markets for EVAR, driven by high procedural volumes, advanced hospital infrastructure, and favorable reimbursement policies. The U.S. has been a leading adopter of EVAR, supported by the presence of major medical device manufacturers, continuous clinical trials, and a skilled vascular surgery workforce. In the European context, countries like Germany, the UK, and the Netherlands demonstrate strong procedural integration within public health systems, with EVAR accounting for over 70% of elective AAA repairs. Government-funded screening initiatives in these regions further fuel patient identification and referral for endovascular treatment.

Asia-Pacific is emerging as a key growth frontier, particularly in Japan, China, and South Korea, where the aging population and urbanization are increasing the incidence of vascular diseases. Japan has been at the forefront in terms of technological adoption, with robust procedural experience and widespread use of custom fenestrated devices. In China, expanding healthcare infrastructure and the development of domestic device manufacturers are enabling rapid market expansion. However, reimbursement disparities and training limitations remain challenges in many emerging economies. In Latin America and parts of the Middle East, adoption is slower but growing, especially in private hospitals catering to higher-income patient segments. Market access strategies such as device leasing, surgical training programs, and hybrid OR installation support are proving effective in these underpenetrated regions.

What Are the Key Forces Powering the Growth of the EVAR Market?

The growth in the endovascular abdominal aortic aneurysm (AAA) market is driven by several factors that collectively shape technology development, procedural adoption, and patient access worldwide. Chief among them is the increasing global prevalence of AAAs, a trend exacerbated by demographic aging, lifestyle-related risk factors, and expanded screening practices. As asymptomatic aneurysms are increasingly detected at an earlier stage, elective EVAR is being prioritized as a safer, less invasive alternative to open surgery. This shift is underpinned by continued innovation in stent graft systems that offer enhanced conformability, sealing capacity, and durability, even in anatomically complex cases.

Regulatory pathways and payer structures are also accelerating growth. With FDA approvals for next-gen devices and CE marks expanding to cover advanced fenestrated and branched solutions, clinical adoption is rising in both traditional and niche anatomical segments. The movement toward value-based healthcare models is aligning well with EVAR's lower complication rates, shorter hospital stays, and reduced postoperative morbidity. Hospitals and surgical centers are investing in hybrid ORs and integrated imaging systems to support these procedures, indicating confidence in the long-term utility of endovascular approaches.

Additionally, industry players are increasingly focused on training and education, launching simulation-based programs and global surgeon networks to standardize procedural expertise. The combination of telehealth for follow-up care and wearable devices for postoperative surveillance is further enriching the treatment ecosystem. Meanwhile, increasing investments in R&D-especially into bioresorbable graft components and AI-enabled imaging tools-suggest that EVAR technology is still in a phase of active evolution. These multifactorial drivers point toward sustained expansion in both procedure volumes and device innovation, firmly establishing EVAR as the dominant modality in AAA management for the foreseeable future.

SCOPE OF STUDY:

The report analyzes the Endovascular Abdominal Aortic Aneurysm (AAA) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Stent Graft, Synthetic Fabric Graft); End-Use (Hospital End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Artivion Inc.
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Cardinal Health Inc.
  • Cook Medical LLC
  • Cordis Corporation
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • Endologix LLC
  • Getinge AB
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Lifetech Scientific Corp.
  • Lombard Medical Ltd.
  • Medtronic plc
  • MicroPort Scientific Corp.
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Endovascular Abdominal Aortic Aneurysm (AAA) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Aortic Aneurysms Among Aging Population Drives Demand for Endovascular Repair
    • Technological Advancements in Stent Graft Designs Propel Growth in Minimally Invasive AAA Treatments
    • Expansion of Screening Programs for Aortic Aneurysms Throws Spotlight on Early Detection and Elective Repair
    • Improved Outcomes and Lower Morbidity Rates Strengthen Business Case for Endovascular Over Open Surgery
    • Integration of 3D Imaging and Navigation Technologies Enhances Precision in Stent Graft Placement
    • Development of Fenestrated and Branched Stent Grafts Expands Addressable Patient Pool With Complex Anatomy
    • Increasing Adoption of EVAR in Ambulatory Surgical Centers Spurs Procedural Volume Growth
    • Regulatory Approvals for Next-Generation Grafts Accelerate Innovation and Clinical Uptake
    • Surge in High-Risk and Comorbid Patients Strengthens Preference for Endovascular Approaches
    • Collaboration With Vascular Surgeons Fuels Device Design Improvements and Workflow Integration
    • Clinical Data Supporting Long-Term Durability of EVAR Devices Encourages Broader Adoption
    • Growing Emphasis on Post-EVAR Surveillance Supports Demand for Follow-Up Imaging Technologies
    • Hospital Investments in Hybrid Operating Rooms Drive Multidisciplinary AAA Repair Capabilities
    • Patient Awareness Campaigns and Screening Initiatives Spur Elective Procedure Rates
    • Payer Reimbursement for Minimally Invasive Aneurysm Repairs Strengthens Financial Accessibility
    • Increasing Use of Contrast-Free and Low-Radiation Imaging Expands EVAR Safety in Renal-Impaired Patients
    • Emerging Use of AI in Aneurysm Morphology Assessment Drives Personalized Device Selection
    • Global Burden of Cardiovascular Disease Supports Government-Funded AAA Screening Programs
    • Focus on Device Miniaturization and Flexibility Enhances Access in Narrow Iliac Arteries
    • Expansion of Training and Simulation Programs Improves Vascular Surgeon Expertise in EVAR Techniques
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Endovascular Abdominal Aortic Aneurysm (AAA) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Stent Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Stent Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Stent Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Synthetic Fabric Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Synthetic Fabric Graft by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Synthetic Fabric Graft by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospital End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • JAPAN
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • CHINA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • EUROPE
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • FRANCE
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • GERMANY
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • INDIA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • AFRICA
    • Endovascular Abdominal Aortic Aneurysm (AAA) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Stent Graft and Synthetic Fabric Graft Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by Product Type - Percentage Breakdown of Value Sales for Stent Graft and Synthetic Fabric Graft for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Endovascular Abdominal Aortic Aneurysm (AAA) by End-Use - Percentage Breakdown of Value Sales for Hospital End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2014, 2025 & 2030

IV. COMPETITION